Results 211 to 220 of about 84,026 (244)

Open-label placebo reduces fatigue in cancer survivors: a randomized trial

Supportive Care in Cancer, 2018
Cancer-related fatigue (CRF) is a common and challenging late effect for many cancer survivors. Clinical trials demonstrate robust placebo effects on CRF in blinded trials. Recently, open-label placebo (OLP) has been shown to improve a variety of symptoms in other populations.
Eric S. Zhou, Kathryn T. Hall, Alexis L. Michaud, Jaime E. Blackmon, Ann H. Partridge, Christopher J. Recklitis   +5 more
openaire   +2 more sources

A Fictionalist Account of Open-Label Placebo

The Journal of Medicine and Philosophy: A Forum for Bioethics and Philosophy of Medicine
Abstract The placebo effect is now generally defined widely as an individual’s response to the psychosocial context of a clinical treatment, as distinct from the treatment’s characteristic physiological effects. Some researchers, however, argue that such a wide definition leads to confusion and misleading implications.
openaire   +2 more sources

Enthusiastic claims for open-label placebo pills ignore the evidence

Pain, 2020
Anita B, Amorim, Gustavo C, Machado, Chris G, Maher   +2 more
openaire   +2 more sources

Einfluss von Open-Label-Placebos auf Kognition und Befinden

Placebos als eigenes Forschungsfeld mit Einsatz als Therapeutika haben in den vergangenen Jahren zunehmend an Bedeutung gewonnen. Bisherige Studien belegen positive Effekte von Placebos auf Faktoren der Lebensqualität (z. B. chronische Schmerzen) in diversen Patientengruppen.
openaire   +1 more source

Semaglutide 2·4 mg once a week in adults with overweight or obesity, and type 2 diabetes (STEP 2): a randomised, double-blind, double-dummy, placebo-controlled, phase 3 trial

Lancet, The, 2021
Melanie Davies, Sue D Pedersen, Leigh Perreault   +2 more
exaly  

Neoadjuvant atezolizumab in combination with sequential nab-paclitaxel and anthracycline-based chemotherapy versus placebo and chemotherapy in patients with early-stage triple-negative breast cancer (IMpassion031): a randomised, double-blind, phase 3 trial

Lancet, The, 2020
Elizabeth A Mittendorf, Shigehira Saji, Kyung Hae Jung   +2 more
exaly  

From Placebo to 'Open-Label Placebo' to Open Altogether

2014
Mommaerts, Jean-Luc, Devroey, Dirk
openaire   +1 more source

Once-daily upadacitinib versus placebo in adolescents and adults with moderate-to-severe atopic dermatitis (Measure Up 1 and Measure Up 2): results from two replicate double-blind, randomised controlled phase 3 trials

Lancet, The, 2021
Andrew Blauvelt, D Thaçi, Chia Yu Chu
exaly  

Investigazione sul potenziale terapeutico dell'effetto placebo open label

Il presente elaborato indaga l’efficacia del placebo open label, trattamento attraverso il quale in modo consapevole e dichiarato vengono somministrati ai pazienti sostanze prive di principio attivo ma che producono comunque dei miglioramenti alleviando o risolvendo i sintomi di alcune condizioni patologiche.
openaire   +1 more source

Implications of Phytoestrogen Intake for Breast Cancer

Ca-A Cancer Journal for Clinicians, 2007
Christine Duffy
exaly